J. Wadsworth

发表

A novel conformationally restricted protein kinase C inhibitor, Ro 31‐8425, inhibits human neutrophil superoxide generation by soluble, particulate and post‐receptor stimuli

P. Davis, M. Dale, B. Twomey, 1991, FEBS letters.

FKBP, thought to be identical to PKCI-2, does not inhibit protein kinase C

Jun S. Liu, S. Schreiber, M. Albers, 1991 .

Sterol carrier protein2-like activity in rat intestine.

R. Chanderbhan, P. Wiesenfeld, L. Gallo, 1988, Journal of lipid research.

Potent selective inhibitors of protein kinase C

P. Davis, S. Wilkinson, G. Lawton, 1989, FEBS letters.

Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases

P. Davis, S. Wilkinson, J. Nixon, 1991, Agents and Actions.

Normal cholesterol absorption in rats deficient in intestinal acyl coenzyme A:cholesterol acyltransferase activity.

L. Gallo, G. Vahouny, J. Wadsworth, 1987, Journal of lipid research.

Oral, anti-inflammatory activity of a potent, selective, protein kinase C inhibitor

P. Davis, S. Wilkinson, G. Lawton, 1992, Agents and Actions.

The design and biological properties of potent and selective inhibitors of protein kinase C.

E. J. Lewis, J. Bishop, P. Davis, 1992, Biochemical Society transactions.

Chemotactic activity of recombinant human interleukin-1

D. Bloxham, D. Westmacott, J. Wadsworth, 1987, Agents and Actions.

Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction.

D. Vesey, P. Davis, P D Davis, 1993, Journal of medicinal chemistry.